Bibliographic details
Vishnu P, Roy V, Paulsen A, Zubair AC. Efficacy and cost-benefit analysis of risk-adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization. Transfusion 2012; 52(1): 55-62
MeSH
Adult; Aged; Cost-Benefit Analysis; Female; Filgrastim; Granulocyte Colony-Stimulating Factor /therapeutic use; Hematopoietic Stem Cell Mobilization /methods; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds /therapeutic use; Humans; Male; Middle Aged; Recombinant Proteins /therapeutic use